Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neurotoxicology

• Publication date

  2005-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEURO.2005.01.017PMID 16002144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preventive pharmacotherapy of headache disorders

  2004cited by this paper
• Regulated Exocytosis Contributes to Protein Kinase C Potentiation of Vanilloid Receptor Activity*

  2004cited by this paper
• Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats.

  2004cited by this paper
• Subcutaneous administration of botulinum toxin A reduces formalin‐induced pain

  2004cited by this paper
• Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy

  2004cited by this paper
• Botulinum Toxin a for Chronic Daily Headache: A Randomized, Placebo-Controlled, Parallel Design Study

  2004cited by this paper
• Botulinum toxin in clinical practice

  2004cited by this paper
• Botulinum Toxin Type A as an Effective Prophylactic Treatment in Primary Headache Disorders

  2003cited by this paper
• Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study

  2003cited by this paper
• Glutamate‐evoked pain and mechanical allodynia in the human masseter muscle

  2003cited by this paper
• Single‐Site Botulinum Toxin Type A Injection for Elimination of Migraine Trigger Points

  2003cited by this paper
• A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A

  2003cited by this paper
• Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery

  2002cited by this paper
• Insights into a basis for incomplete inhibition by botulinum toxin A of Ca2+-evoked exocytosis from permeabilised chromaffin cells.

  2002cited by this paper
• Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.

  2002cited by this paper
• Stress, inflammation and cardiovascular disease.

  2002cited by this paper
• Second phase of formalin‐induced excitation of spinal dorsal horn neurons in spinalized rats is reversed by sciatic nerve block

  2002cited by this paper
• Botulinum Toxin Type A as a Migraine Preventive Treatment

  2000cited by this paper
• Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

  2000cited by this paper
• Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat.

  2000cited by this paper
• Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.

  2000cited by this paper
• Peripheral glutamate release in the hindpaw following low and high intensity sciatic stimulation

  2000cited by this paper
• Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses.

  1999cited by this paper
• Inflammation-induced changes in peripheral glutamate receptor populations.

  1999cited by this paper
• Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery

  1998cited by this paper
• Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw.

  1998cited by this paper
• The human capsaicin model of allodynia and hyperalgesia: sources of variability and methods for reduction.

  1998cited by this paper
• Differential contribution of the two phases of the formalin test to the pattern of c‐fos expression in the rat spinal cord: studies with remifentanil and lidocaine

  1997cited by this paper
• Formalin‐evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase‐2 activity

  1996cited by this paper
• Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats

  1996cited by this paper
• Ketoprofen produces profound inhibition of spinal c‐Fos protein expression resulting from an inflammatory stimulus but not from noxious heat

  1996cited by this paper
• The contribution of NMDA receptor activation to spinal c‐Fos expression in a model of inflammatory pain

  1995cited by this paper
• Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin.

  1995cited by this paper
• Exaggerated cardiovascular and behavioral nociceptive responses to subcutaneous formalin in the spontaneously hypertensive rat.

  1995cited by this paper
• Botulinum toxin A for spasticity, muscle spasms, and rigidity

  1995cited by this paper
• Dextromethorphan suppresses both formalin‐induced nociceptive behavior and the formalin‐induced increase in spinal cord c‐fos mRNA

  1995cited by this paper
• Tension Headache: Botulinum Toxin Paralysis of Temporal Muscles

  1994cited by this paper
• Differential effects of morphine on noxious stimulus-evoked fos-like immunoreactivity in subpopulations of spinoparabrachial neurons

  1994cited by this paper
• Botulinum toxin in the treatment of myofascial pain syndrome

  1994cited by this paper
• Electrophysiologic Analysis of Preemptive Effects of Spinal Opioids on N-methyl-D-aspartate Receptor--mediated Events

  1994cited by this paper
• Significant improvement of stiff‐person syndrome after paraspinal injection of botulinum toxin A

  1993cited by this paper
• Noradrenergic modulation of noxious heat‐evoked fos‐like immunoreactivity in the dorsal horn of the rat sacral spinal cord

  1992cited by this paper
• Writer's cramp: Treatment with botulinum toxin injections

  1991cited by this paper
• Descending adrenergic input to the primate spinal cord and its possible role in modulation of spinothalamic cells.

  1991cited by this paper
• Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat.

  1990cited by this paper
• Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection.

  1990cited by this paper
• Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord

  1990cited by this paper
• Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

  1987cited by this paper
• Subcutaneous formalin‐induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin

  1987cited by this paper
• Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones.

  1987cited by this paper
• Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves

  1986cited by this paper
• Botulinum toxin types A, B and D inhibit catecholamine secretion from bovine adrenal medullary cells

  1986cited by this paper
• Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis

  1986cited by this paper
• Double-blind study of botulinum toxin in spasmodic torticollis.

  1986cited by this paper
• Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord

  1981cited by this paper
• The origin, structure, and pharmacological activity of botulinum toxin.

  1981cited by this paper
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

  1981cited by this paper
• PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY.

  1964cited by this paper

• The Use of Botulinum Toxin Injections in Peripheral Neuropathic Pain: A Systematic Review of Efficacy and Safety Outcomes

  2026cites this paper
• Central and Peripheral Sensitization in Temporomandibular Disorders: Proposed Mechanisms of Botulinum Toxin Therapy

  2026cites this paper
• Botulinum Toxin Type A for the Prevention of Migraines: An Umbrella Review of Systematic Reviews

  2026cites this paper
• Efficacy of adipose stromal cells-enriched high-density fat graft combined with BTX-A for Raynaud’s phenomenon: a prospective cohort study

  2025cites this paper
• Beyond Dystonia: The Therapeutic Benefits of Botulinum Toxin Type A in Neurological Disorders

  2025cites this paper
• USO INTRA-ARTICULAR DE TOXINA BOTULÍNICA NA OSTEOARTRITE DE JOELHO: UMA REVISÃO DE LITERATURA RECENTE

  2025cites this paper
• Migraine Relief Through Botulinum Toxin Therapy: Exploring the Science Behind a Modern Treatment.

  2025cites this paper
• Clinical impacts of botulinum toxin type A injections for provoked vestibulodynia: insights from randomized controlled trials

  2025cites this paper
• Chewing Dystonia and Sensory Modulation: An Exploratory Study of Intraoral Lidocaine Effects

  2025cites this paper
• Botulinum toxin improved intestinal adaptation to short gut in a twenty-one-day-old weanling rat

  2025cites this paper
• A Case Report of Intraoral Injection of Botulinum Toxin A for Trigeminal Neuralgia: A Rare but Safe Intervention

  2025cites this paper
• BoNT Injection into Temporomandibular Joint Alleviates TMJ Pain in Forced Mouth Opening Mouse Model

  2025cites this paper
• Botulinum Therapy for Pain Caused by Spasticity in Advanced Stages of Brain Tumor in Adolescents: A Case Report

  2025cites this paper
• BOTULINUM TOXIN TYPE A IN THE TREATMENT OF CHRONIC MIGRAINE: CURRENT STATE OF KNOWLEDGE AND THERAPEUTIC PERSPECTIVES

  2025cites this paper
• Comprehensive pain management in spinal surgery: The role of botulinum toxin.

  2025cites this paper
• Changes in brainstem habituation during onabotulinumtoxinA treatment in chronic migraine: A prospective case-control study.

  2025cites this paper
• Effects of botulinum toxin type A in a migraine-specific animal model

  2025cites this paper
• Botulinum toxin type A inhibits hyperalgesia in the rat masseter muscle in a carrageenan model of myofascial pain.

  2025cites this paper
• Early effect of onabotulinumtoxinA on EEG‐based functional connectivity in patients with chronic migraine: A pilot study

  2024cites this paper
• A Comparative Analysis of Botulinum Toxin Use Versus Other Therapies for Temporomandibular Disorders: A Systematic Review

  2024cites this paper
• Non-Migraine Head Pain and Botulinum Toxin

  2024cites this paper
• Treatment of myofascial pain and dysfunction using botulinum toxin A: a prospective study

  2024cites this paper
• Cellular and molecular mechanisms involved in the analgesic effects of botulinum neurotoxin: A literature review

  2024cites this paper
• Syndromes de la traversée cervico-thoraco-brachiale

  2024cites this paper
• Intramuscular Botulinum Toxin as an Adjunct to Arthrocentesis with Viscosupplementation in Temporomandibular Disorders: A Proof-of-Concept Case–Control Investigation

  2024cites this paper
• Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine

  2024cites this paper
• Efficacy and safety profile of Onabotulinum toxin-A injection at sphenopalatine ganglion in trigeminal neuralgia: a prospective observational study

  2024cites this paper
• Procedural interventions for erythromelalgia: A narrative review

  2024cites this paper
• Botulism

  2024cites this paper
• Botulinum toxin A for the management of temporomandibular myofascial pain: A cohort study.

  2024cites this paper
• Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia

  2024cites this paper
• Effects of botulinum toxin type A on the masseter muscles of a patient with a temporomandibular joint disorder of muscular origin: A case report

  2024cites this paper
• Adverse effects of treating bruxism and masseter muscle hypertrophy with botulinum toxin injection - a literature review

  2024cites this paper
• Interventional Management Of Neuropathic Ocular Pain – A Scoping Review

  2024cites this paper
• Efficacy and safety of intra-articular botulinum toxin injection therapy for joint pain: A systematic review and meta-analysis.

  2024cites this paper
• Onabotulinumtoxin A for the Treatment of Post-Traumatic Headache: Is It Better than Anti-CGRP Antibodies?

  2024cites this paper
• Therapeutic efficacy and safety of botulinum toxin A injection in plantar fasciitis: A systematic review and meta-analysis

  2024cites this paper
• Intra-Articular Injection of Botulinum Toxin for the Treatment of Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials

  2023cites this paper
• Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study

  2023cites this paper
• Intramuscular injections of botulinum toxin for the treatment of upper back myofascial pain syndrome: A systematic review of randomized controlled trials

  2023cites this paper
• Botulinum Neurotoxin Type a Injection Combined with Absorbable Punctal Plug Insertion: An Effective Therapy for Blepharospasm Patients with Dry Eye

  2023cites this paper
• What Is the Efficacy of Intra-articular Injections in the Treatment of Ankle Osteoarthritis? A Systematic Review

  2023cites this paper
• Botulinum Neurotoxins: From Toxin to Medicine

  2023cites this paper
• New botulinum neurotoxin constructs for treatment of chronic pain

  2023cites this paper
• Early Wearing-Off Effect of OnabotulinumtoxinA in Chronic Migraine: A Prospective Real-Life Study

  2023cites this paper
• Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates

  2023cites this paper
• Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review

  2023cites this paper
• The application and therapeutic effect of botulinum toxin type a (BTX-A) in the treatment of patients with pain after cancer treatment: a systematic review and meta-analysis

  2023cites this paper
• Multidisciplinary management of people with spina bifida across the lifespan

  2023cites this paper
• Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2023cites this paper
• Botulinum toxin A and neuropathic pain: An update.

  2023cites this paper
• A Novel Regimen of Transdermal Botulinum Toxin Delivery Using Fractional Microneedling Radiofrequency for Treatment of Erythema in Rosacea

  2023cites this paper
• Possible role of the botulinum toxin in the management of neurogenic thoracic outlet syndrome: a systematic review

  2023cites this paper
• Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders

  2023cites this paper
• Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety

  2023cites this paper
• How Does Botulinum Toxin Inhibit Itch?

  2022cites this paper
• Efficacy of Ultrasound-Guided Injection of Botulinum Toxin, Ozone, and Lidocaine in Piriformis Syndrome

  2022cites this paper
• Botulinum Toxin for Scalp Dysesthesia

  2022influential citation
• Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices

  2022cites this paper
• Nummular headache responsive to anti‐calcitonin gene‐related peptide monoclonal antibodies in a patient with migraine

  2022cites this paper
• Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine

  2022cites this paper
• Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art

  2022influential citation
• Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?

  2022cites this paper
• A systematic review on extracorporeal shock wave therapy and botulinum toxin for spasticity treatment: a comparison on efficacy.

  2022cites this paper
• Generalized Anxiety Disorder: A Predictor for Poor Responsiveness to Botulinum Toxin Type A Therapy for Pediatric Migraine.

  2022cites this paper
• New Insights on Metabolic and Genetic Basis of Migraine: Novel Impact on Management and Therapeutical Approach

  2022cites this paper
• Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice

  2022cites this paper
• USO DA TOXINA BOTULÍNICA EM CASOS DE BRUXISMO: UMA REVISÃO ATUALIZADA

  2022cites this paper
• THE EFFECTS OF BOTULINUM TOXIN IN MYOFASCIAL PAIN MODULATION: NEW PERSPECTIVES FOR ESTHETIC AND FUNCTIONAL DENTISTRY

  2022cites this paper
• Botulinum Toxin for Neurogenic and Non-neurogenic Bladder Pain

  2022cites this paper
• Treatment Options for Patellofemoral Arthritis

  2022cites this paper
• A preliminary trial of botulinum toxin type A in patients with vestibular migraine: A longitudinal fMRI study

  2022cites this paper
• Facets of the problem of infiltrative endometriosis: from pathogenesis to effective therapy

  2021cites this paper
• The efficacy of botulinum toxin type-A for intractable chronic migraine patients with no pain-free time

  2021cites this paper
• Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine

  2021cites this paper
• The Anti-Nociceptive/Anti-Inflammatory Actions of Botulinum Toxin A for the Treatment of Chronic Pain; A Literature Review

  2021cites this paper
• Foot and Ankle Injections in Athletes

  2021cites this paper
• Current use of botulinum neurotoxin in esthetic practice—Clinical guide and review

  2021cites this paper
• Thoracic Outlet Syndrome: A Narrative Review

  2021cites this paper
• Botulinum toxin as a novel therapeutic approach for auriculotemporal neuralgia

  2021cites this paper
• Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives

  2021cites this paper
• Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines

  2021cites this paper
• Does the Use of Botulinum Toxin Reduce the Intensity of Myofascial Pain in Adult Patients? A Systematic Review and Meta-Analysis

  2021cites this paper
• Evaluation and Management of Neurogenic Thoracic Outlet Syndrome with an Overview of Surgical Approaches: A Comprehensive Review

  2021cites this paper
• Pain Due To Pathologicalspontaneous Bone Fracture: Interest Of Botulinum Toxin.

  2021cites this paper
• Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia

  2021cites this paper
• Trigeminal neuralgia: updated management

  2021cites this paper
• Therapeutic Effects of Intra-articular Botulinum Neurotoxin Versus Physical Therapy in Knee Osteoarthritis

  2021cites this paper
• Prophylaxis of Migraine Protocols and Options

  2021cites this paper
• Neurocosmetics in Skincare—The Fascinating World of Skin–Brain Connection: A Review to Explore Ingredients, Commercial Products for Skin Aging, and Cosmetic Regulation

  2021cites this paper
• Systematic Review Effectiveness of Botulinum Toxin in Managing Temporomandibular Disorders: A Systematic Review

  2021cites this paper
• Innovations in the Management of Temporomandibular Joint Disorders

  2021cites this paper
• Oily sensitive skin: A review of management options

  2020cites this paper
• Decreased mandibular cortical bone quality after botulinum toxin injections in masticatory muscles in female adults

  2020cites this paper
• Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study

  2020cites this paper
• The Role Of Botox In The Management Of Tmj Disorders – A Systematic Review

  2020cites this paper
• Botulinum toxin in the management of temporomandibular disorders: a systematic review.

  2020cites this paper
• Botulinum toxin for the treatment of erythema and flushing of rosacea with two different techniques: intradermal injections and facial electroporation

  2020cites this paper
• Pain.

  2020cites this paper
• Guidelines for botulinum neurotoxin injections in piriformis syndrome

  2020cites this paper